Colon cancer develops in the tissues of the colon, while rectal cancer forms in the rectum, the final portion of the large intestine. Together, these conditions are often referred to as colorectal cancer and are among the most commonly diagnosed cancers. When detected early, colon cancer is highly treatable and, in many cases, preventable. Routine screening can identify abnormal growths before they become cancerous, making early detection one of the most powerful tools in reducing the severity and impact of the disease.
Despite the effectiveness of screening tools, many cases of colon cancer are not diagnosed until the disease has progressed. Symptoms such as rectal bleeding, changes in bowel habits, abdominal pain, or unexplained anemia may be overlooked or attributed to less serious conditions. When warning signs are dismissed or appropriate screening tests are not ordered, valuable time may be lost, allowing cancer to spread and limiting treatment options.
Colon cancer often begins as benign polyps that can be identified and removed during routine screening. Early detection methods may include stool-based tests to identify hidden blood, followed by colonoscopy to closely examine the colon and remove suspicious growths. When these screenings are performed appropriately, they can significantly reduce the risk of advanced disease.
Delayed or missed colon cancer diagnoses frequently result from preventable medical errors, including:
When colon cancer is not diagnosed at an early stage, the disease is more likely to spread to surrounding tissue or distant organs. As cancer advances, treatment often becomes more invasive and less effective, leading to increased physical pain, emotional distress, and financial burden. Earlier detection can dramatically improve outcomes and survival rates.
Blume Forte carefully reviews medical records, screening histories, test results, and treatment timelines to determine whether the standard of care was met. The firm works with qualified medical experts to assess how earlier diagnosis could have altered treatment options or outcomes. With a strong history of success in delayed cancer diagnosis cases, Blume Forte is committed to helping individuals and families pursue accountability, financial recovery, and clarity after a failure to diagnose colon cancer.
What to Expect
VIEW
( 01 )